Hikma Pharmaceuticals PLC ORD SHS.../ GB00B0LCW083 /
9/11/2024 9:00:00 PM | Chg. +15.0000 | Volume | Bid9/11/2024 | Ask9/11/2024 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
1,932.0000GBX | +0.78% | 188,283 Turnover(GBP): 3.63 mill. |
1,195.0000Bid Size: 6,000 | 2,100.0000Ask Size: 4,600 | 4.27 bill.GBP | - | - |
Assets
2013 IFRS in mill. USD |
2014 IFRS in mill. USD |
2015 IFRS in mill. USD |
2016 IFRS in mill. USD |
2017 IFRS in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 443 | 514 | 507 | 969 | 828 | ||||||
Intangible Assets | 447 | 602 | 607 | 1,037 | 503 | ||||||
Long-Term Investments | 56 | 55 | 53 | 55 | 66 | ||||||
Fixed Assets | 1,032 | 1,238 | 1,237 | 2,915 | 1,814 | ||||||
Inventories | 276 | 273 | 251 | 459 | 488 | ||||||
Accounts Receivable | 439 | 439 | 488 | 759 | 707 | ||||||
Cash and Cash Equivalents | 168 | 280 | 553 | 155 | 227 | ||||||
Current Assets | 897 | 1,013 | 1,360 | 1,448 | 1,574 | ||||||
Total Assets | 1,929 | 2,251 | 2,597 | 4,363 | 3,388 |
Liabilities
2013 IFRS in mill. USD |
2014 IFRS in mill. USD |
2015 IFRS in mill. USD |
2016 IFRS in mill. USD |
2017 IFRS in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 241 | 248 | 276 | 343 | 365 | ||||||
Long-term debt | 263 | 145 | 590 | 721 | 670 | ||||||
Liabilities to Banks | 422 | 538 | 705 | 838 | 756 | ||||||
Provisions | 46 | 50 | 49 | 42 | 75 | ||||||
Liabilities | 895 | 1,035 | 1,245 | 1,952 | 1,860 | ||||||
Share Capital | 35.2000 | 35.2000 | 35.2000 | 40 | 40 | ||||||
Total Equity | 1,017 | 1,197 | 1,337 | 2,396 | 1,514 | ||||||
Minority Interests | 17 | 19 | 15 | 15 | 14 | ||||||
Total liabilities equity | 1,929 | 2,251 | 2,597 | 4,363 | 3,388 |
Income Statement
2013 IFRS in mill. USD |
2014 IFRS in mill. USD |
2015 IFRS in mill. USD |
2016 IFRS in mill. USD |
2017 IFRS in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 1,365 | 1,489 | 1,440 | 1,950 | 1,936 | ||||||
Depreciation (total) | - | - | - | - | - | ||||||
Operating Result | 352 | 402 | 381 | 302 | -747 | ||||||
Interest Income | - | - | - | - | - | ||||||
Income Before Taxes | 298 | 362 | 318 | 210 | -738 | ||||||
Income Taxes | -82 | -80 | -64 | -52 | -101 | ||||||
Minority Interests Profit | -4 | -4 | -2 | -3 | -4 | ||||||
Net Income | 212 | 278 | 252 | 155 | -843 |
Per Share
Cash Flow
2013 IFRS in mill. USD |
2014 IFRS in mill. USD |
2015 IFRS in mill. USD |
2016 IFRS in mill. USD |
2017 IFRS in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 337 | 425 | 366 | 293 | 443 | ||||||
Cash Flow from Investing Activities | -115 | -342 | -162 | -695 | -151 | ||||||
Cash Flow from Financing | -229 | 30 | 77 | 19 | -220 | ||||||
Decrease / Increase in Cash | -7 | 113 | 281 | -383 | 72 | ||||||
Employees | 7,067 | 7,139 | 7,189 | 8,339 | 8,521 |